Literature DB >> 25595774

Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1.

Christine B Read1, Joseph L Kuijper2, Siv A Hjorth3, Mark D Heipel2, Xiaoting Tang2, Andrew J Fleetwood1, Jeffrey L Dantzler2, Susanne N Grell1, Jesper Kastrup1, Camilla Wang2, Cameron S Brandt2, Anker J Hansen1, Nicolai R Wagtmann1, Wenfeng Xu2, Vibeke W Stennicke4.   

Abstract

Triggering receptor expressed on myeloid cells (TREM)-1 is an orphan receptor implicated in innate immune activation. Inhibition of TREM-1 reduces sepsis in mouse models, suggesting a role for it in immune responses triggered by bacteria. However, the absence of an identified ligand has hampered a full understanding of TREM-1 function. We identified complexes between peptidoglycan recognition protein 1 (PGLYRP1) and bacterially derived peptidoglycan that constitute a potent ligand capable of binding TREM-1 and inducing known TREM-1 functions. Interestingly, multimerization of PGLYRP1 bypassed the need for peptidoglycan in TREM-1 activation, demonstrating that the PGLYRP1/TREM-1 axis can be activated in the absence of bacterial products. The role for PGLYRP1 as a TREM-1 activator provides a new mechanism by which bacteria can trigger myeloid cells, linking two known, but previously unrelated, pathways in innate immunity.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25595774      PMCID: PMC4319313          DOI: 10.4049/jimmunol.1402303

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock.

Authors:  Sébastien Gibot; Cecilia Buonsanti; Frédéric Massin; Michele Romano; Marie-Nathalie Kolopp-Sarda; Fabio Benigni; Gilbert C Faure; Marie-Christine Béné; Paola Panina-Bordignon; Nadia Passini; Bruno Lévy
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  High dynamic range characterization of the trauma patient plasma proteome.

Authors:  Tao Liu; Wei-Jun Qian; Marina A Gritsenko; Wenzhong Xiao; Lyle L Moldawer; Amit Kaushal; Matthew E Monroe; Susan M Varnum; Ronald J Moore; Samuel O Purvine; Ronald V Maier; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-05-09       Impact factor: 5.911

3.  Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity.

Authors:  Ju Hyun Cho; Iain P Fraser; Koichi Fukase; Shoichi Kusumoto; Yukari Fujimoto; Gregory L Stahl; R Alan B Ezekowitz
Journal:  Blood       Date:  2005-06-14       Impact factor: 22.113

4.  LacZ inducible, antigen/MHC-specific T cell hybrids.

Authors:  S Sanderson; N Shastri
Journal:  Int Immunol       Date:  1994-03       Impact factor: 4.823

5.  Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus.

Authors:  Agnieszka Bera; Silvia Herbert; Andreas Jakob; Waldemar Vollmer; Friedrich Götz
Journal:  Mol Microbiol       Date:  2005-02       Impact factor: 3.501

Review 6.  Peptidoglycan recognition proteins in Drosophila immunity.

Authors:  Shoichiro Kurata
Journal:  Dev Comp Immunol       Date:  2013-06-22       Impact factor: 3.636

7.  Selective recognition of synthetic lysine and meso-diaminopimelic acid-type peptidoglycan fragments by human peptidoglycan recognition proteins I{alpha} and S.

Authors:  Sanjay Kumar; Abhijit Roychowdhury; Brian Ember; Qian Wang; Rongjin Guan; Roy A Mariuzza; Geert-Jan Boons
Journal:  J Biol Chem       Date:  2005-08-29       Impact factor: 5.157

8.  A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response.

Authors:  Joshua R Bleharski; Viviane Kiessler; Cecilia Buonsanti; Peter A Sieling; Steffen Stenger; Marco Colonna; Robert L Modlin
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

9.  Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival.

Authors:  Markus P Radsak; Helmut R Salih; Hans-Georg Rammensee; Hansjörg Schild
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

10.  A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis.

Authors:  Sébastien Gibot; Marie-Nathalie Kolopp-Sarda; Marie-C Béné; Pierre-Edouard Bollaert; Alain Lozniewski; Françoise Mory; Bruno Levy; Gilbert C Faure
Journal:  J Exp Med       Date:  2004-11-22       Impact factor: 14.307

View more
  61 in total

1.  Identification of a Novel Splice Variant Isoform of TREM-1 in Human Neutrophil Granules.

Authors:  Sankar Baruah; Kathy Keck; Michelle Vrenios; Marshall R Pope; Merideth Pearl; Kevin Doerschug; Julia Klesney-Tait
Journal:  J Immunol       Date:  2015-11-11       Impact factor: 5.422

2.  Peripheral TREM1 responses to brain and intestinal immunogens amplify stroke severity.

Authors:  Qingkun Liu; Emily M Johnson; Rachel K Lam; Qian Wang; Hong Bo Ye; Edward N Wilson; Paras S Minhas; Ling Liu; Michelle S Swarovski; Stephanie Tran; Jing Wang; Swapnil S Mehta; Xi Yang; Joshua D Rabinowitz; Samuel S Yang; Mehrdad Shamloo; Christoph Mueller; Michelle L James; Katrin I Andreasson
Journal:  Nat Immunol       Date:  2019-07-01       Impact factor: 25.606

Review 3.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases.

Authors:  Tao Gong; Lei Liu; Wei Jiang; Rongbin Zhou
Journal:  Nat Rev Immunol       Date:  2019-09-26       Impact factor: 53.106

4.  Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.

Authors:  Athena Sudom; Santosh Talreja; Jean Danao; Eric Bragg; Rob Kegel; Xiaoshan Min; Jason Richardson; Zhongqi Zhang; Nikolai Sharkov; Edoardo Marcora; Steve Thibault; Jodi Bradley; Steve Wood; Ai-Ching Lim; Hang Chen; Songli Wang; Ian N Foltz; Shilpa Sambashivan; Zhulun Wang
Journal:  J Biol Chem       Date:  2018-05-24       Impact factor: 5.157

5.  Extracellular CIRP as an endogenous TREM-1 ligand to fuel inflammation in sepsis.

Authors:  Naomi-Liza Denning; Monowar Aziz; Atsushi Murao; Steven D Gurien; Mahendar Ochani; Jose M Prince; Ping Wang
Journal:  JCI Insight       Date:  2020-03-12

Review 6.  Peptidoglycan recognition by the innate immune system.

Authors:  Andrea J Wolf; David M Underhill
Journal:  Nat Rev Immunol       Date:  2018-01-02       Impact factor: 53.106

7.  Immunobiotic Lactobacillus administered post-exposure averts the lethal sequelae of respiratory virus infection.

Authors:  Caroline M Percopo; Tyler A Rice; Todd A Brenner; Kimberly D Dyer; Janice L Luo; Kishore Kanakabandi; Daniel E Sturdevant; Stephen F Porcella; Joseph B Domachowske; Jesse D Keicher; Helene F Rosenberg
Journal:  Antiviral Res       Date:  2015-07-02       Impact factor: 5.970

8.  TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine.

Authors:  Zhihong Yuan; Mansoor Syed; Dipti Panchal; Myungsoo Joo; Chetna Bedi; Sokbee Lim; Hayat Onyuksel; Israel Rubinstein; Marco Colonna; Ruxana T Sadikot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

9.  Novel TREM-1 Inhibitors Attenuate Tumor Growth and Prolong Survival in Experimental Pancreatic Cancer.

Authors:  Zu T Shen; Alexander B Sigalov
Journal:  Mol Pharm       Date:  2017-11-13       Impact factor: 4.939

10.  Activation of the TREM-1 pathway in human monocytes by periodontal pathogens and oral commensal bacteria.

Authors:  M Varanat; E M Haase; J G Kay; F A Scannapieco
Journal:  Mol Oral Microbiol       Date:  2016-09-06       Impact factor: 3.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.